These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8903079)
21. Atypical MR findings in Wilson's disease: pronounced lesions in the dentate nucleus causing tremor. Matsuura T; Sasaki H; Tashiro K J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):161. PubMed ID: 9489523 [No Abstract] [Full Text] [Related]
22. Ocular motility and Wilson's disease: a study on 34 patients. Ingster-Moati I; Bui Quoc E; Pless M; Djomby R; Orssaud C; Guichard JP; Woimant F J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1199-201. PubMed ID: 17470473 [TBL] [Abstract][Full Text] [Related]
23. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Westermark K; Tedroff J; Thuomas KA; Hartvig P; Långström B; Andersson Y; Hörnfeldt K; Aquilonius SM Mov Disord; 1995 Sep; 10(5):596-603. PubMed ID: 8552111 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of neurological Wilson's disease with corpus callosum abnormalities. Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106 [TBL] [Abstract][Full Text] [Related]
25. Kayser-Fleischer ring in Wilson's disease: a cohort study. Fenu M; Liggi M; Demelia E; Sorbello O; Civolani A; Demelia L Eur J Intern Med; 2012 Sep; 23(6):e150-6. PubMed ID: 22863441 [TBL] [Abstract][Full Text] [Related]
26. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration]. Grau-Veciana JM; Barraquer-Bordas L Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136 [No Abstract] [Full Text] [Related]
27. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease. Berger B; Mader I; Damjanovic K; Niesen WD; Stich O Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257 [No Abstract] [Full Text] [Related]
28. Membranoproliferative glomerulonephritis in a patient with Wilson's disease. Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260 [TBL] [Abstract][Full Text] [Related]
30. Axonal sensory motor neuropathy in copper-deficient Wilson's disease. Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919 [TBL] [Abstract][Full Text] [Related]
31. [Magnetic Resonance Imaging Improvement in a Patient with Wilson's Disease Following Treatment with Trientine Hydrochloride and Zinc Acetate]. Kim Y; Koide R; Kawata A Brain Nerve; 2015 May; 67(5):635-8. PubMed ID: 25957210 [TBL] [Abstract][Full Text] [Related]
32. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases. Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197 [TBL] [Abstract][Full Text] [Related]
35. Quantitative transcranial sonography in Wilson's disease and healthy controls: Cut-off values and functional correlates. Tribl GG; Trindade MC; Almeida KJ; Alves RC; de Andrade DC; Fonoff ET; Machado AA; Teixeira MJ; Barbosa ER; Bor-Seng-Shu E J Neurol Sci; 2018 Feb; 385():69-74. PubMed ID: 29406916 [TBL] [Abstract][Full Text] [Related]
36. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment. Chung EJ; Kim EG; Kim SJ; Ji KH; Seo JH Neurocase; 2016; 22(1):40-4. PubMed ID: 25988284 [TBL] [Abstract][Full Text] [Related]